Roles of Individual Institutions in Achieving Pharmaceutical Sovereignty as Exemplified by the Medical Technology Transfer Centre of the Scientific Centre for Expert Evaluation of Medicinal Products

QR Code

Roles of Individual Institutions in Achieving Pharmaceutical Sovereignty as Exemplified by the Medical Technology Transfer Centre of the Scientific Centre for Expert Evaluation of Medicinal Products

INTRODUCTION. The strengthening of the health system and the improvement of access to medicines directly depend on the development and marketing authorisation of national innovative medicinal products. Technology transfer is a key tool in bringing medicinal products to market.AIM. This study aimed t...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. S. Koshevenko, T. V. Degrave, P. V. Burenkov, K. Yu. Belanov, V. V. Kosenko
Format:	Article
Language:	Russian
Published:	Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) 2024-11-01
Series:	Регуляторные исследования и экспертиза лекарственных средств
Subjects:	technology transfer pharmaceutical development innovative development pharmaceutical industry medical science federal project scientific centre for expert evaluation of medicinal products pharmaceutical sovereignty
Online Access:	https://www.vedomostincesmp.ru/jour/article/view/707
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Documentation of Pharmaceutical Development. Part 2. Quality System Documents
by: I. E. Smekhova, et al.
Published: (2021-05-01)

Development of Retraining Systems for the Implementation of the Pharmaceutical Quality System at Pharmaceutical Production Enterprises of the EAEU Countries
by: V. A. Smirnov, et al.
Published: (2021-02-01)

Pharmaceutical Innovations: Artificial Intelligence and Scientific Cooperation as the Certain Future for the Pharmaceutical Industry
by: L. I. Shcherbakova, et al.
Published: (2025-05-01)

THE MANUFACTURING OF PHARMACEUTICAL INGREDIENTS IN RUSSIAN FEDERATION: THE CRISIS AT THE TURN OF XX TO XXI CENTURIES
by: E. V. Denisova
Published: (2019-01-01)

Pharmaceutical care for patients with coronary heart disease: transformation of pharmaceutical practice
by: N. A. Bilousova
Published: (2024-11-01)

Documentation of Pharmaceutical Development. Part 1. Study of the Documentation of the Site
by: I. E. Smekhova, et al.
Published: (2021-02-01)

TO 55-YEAR ANNIVERSARY OF PHARMACEUTICAL FACULTY OF THE I.M. SECHENOV FIRST MSMU
by: M. S. Sergeeva
Published: (2013-09-01)

Pharmaceutical care as a historical, normative-legal and social-economic category in the system of the population health and pharmaceutical care
by: G. L. Panfilova
Published: (2014-08-01)

PHARMACEUTICAL DEVELOPMENT OF DRUGS FOR PEDIATRIC PRACTICE: FUNDAMENTAL BASES AND SPECIFIC FEATURES
by: I. A. Narkevich, et al.
Published: (2019-01-01)

Encyclopedia of pharmaceutical technology /
Published: (1988)

INNOVATIVE PROCESSES IN THE RUSSIAN PHARMACEUTICAL MARKET
by: E. A. Bykova
Published: (2020-09-01)

Analysis of the current state and prospects for the development of sedatives in the modern Ukrainian pharmaceutical market
by: S. A. Hladyshevа, et al.
Published: (2021-03-01)

Conceptual and category apparatus of legislation, what determines legal responsibility in pharmaceutical activity
by: O. H. Aleksieiev
Published: (2022-08-01)

THE USE OF THE IDEF0 STANDARD IN PREPARATION FOR PHARMACEUTICAL DEVELOPMENT
by: S. A. Rozhnova, et al.
Published: (2019-01-01)

Introduction of the concept of social responsibility in the activity of pharmaceutical organizations
by: N. О. Tkachenko
Published: (2018-08-01)

PROJECT-ORIENTED APPROACH TO FINISHED PHARMA PRODUCT DEVELOPMENT IN THE CONTEXT OF GENERIC POLYCOMPONENT DRUG CONTAINING AMOXYCILLIN AND CLAVULANIC ACID
by: Yu. V. Vlasenko
Published: (2019-01-01)

MODELING PROCESS OF PALLIATIVE PHARMACEUTICAL CARE AS A COMPONENT OF PHARMACEUTICAL SAFETY AT THE LOCAL LEVEL
by: I. A. Tueva, et al.
Published: (2018-07-01)

Pharmaceutical Substances. Requirements of the State Pharmacopoeia for Their Standardization
by: E. I. Sakanyan, et al.
Published: (2020-05-01)

Prescriptions for death the drugging of the Third World
by: Silverman, Milton Morris, 1910-
Published: (1982)

Research of the information security environment of pharmaceutical organizations in the context of the transformation of pharmaceutical practice
by: N. O. Tkachenko, et al.
Published: (2025-07-01)

ANALYSIS OF PHARMACEUTICAL COMPANIES’ ACTIVITIES THAT ARE DIRECTED TO PHYSICIANS IN EGYPT
by: M. M. Bahlol, et al.
Published: (2016-03-01)

ANALYSIS OF THE SYSTEM ORGANIZATION OF PHARMACEUTICAL DRUG DEVELOPMENT
by: S. A. Rozhnova, et al.
Published: (2019-01-01)

Problematic aspects of staffing the domestic pharmacy segment in the context of pharmaceutical safety
by: N. O. Tkachenko, et al.
Published: (2025-03-01)

The Quality Risk Assessment of Paralithodes Camtschaticus Collagenase Gel in the Process of Pharmaceutical Development
by: Ju. O. Ivankova, et al.
Published: (2023-09-01)

PHARMACEUTICAL DEVELOPMENT OF FORMULATION BASED ON BIOPHARMACEUTICAL PREPARATIONS FOR GENE THERAPY
by: T. V. Budylskaya, et al.
Published: (2019-01-01)

Pharmaceutical advertising on child-focused television networks in Russia: is there a need for change?
by: A. E. Imaeva, et al.
Published: (2020-03-01)

ACTIVE SUBSTANCES FOR DOMESTIC MANUFACTURER OF MEDICINES: PAST, PRESENT AND FUTURE
by: K. O. Sidorov, et al.
Published: (2019-01-01)

Analysis of Russian pharmaceutical specialists labor market for 2019–2022
by: D. V. Kurkin, et al.
Published: (2024-11-01)

IN MEMORY OF PROFESSOR V.G. BELIKOV
by: B. V. Borovsky, et al.
Published: (2015-09-01)

Toxicity Removal of Pharmaceuticals Mixtures through Electron Beam Irradiation
by: NAthalia Fonseca Boiani, et al.
Published: (2022-12-01)

TO THE 90TH ANNIVERSARY OF BIRTHDAY OF PROFESSOR V.G. BELIKOV
by: B. V. Borovsky, et al.
Published: (2015-11-01)

Polymer systems for solid pharmaceuticals
Published: (2008-06-01)

Implementation of pharmaceutical development using multivariate analysis of multi-criteria optimization on the example of the stage of purification of oligohexamethyleneguanidine hydrosuccinate
by: D. O. Shatalov, et al.
Published: (2023-08-01)

CURRENT TRENDS AND PROSPECTS OF THE RUSSIAN PHARMACEUTICAL INDUSTRY AND THE FOREIGN EXPERIENCE
by: Z. A. Mamedyarov
Published: (2018-01-01)

COMPARATIVE ANALYSIS OF THE DOMESTIC AND FOREIGN PHARMACEUTICAL MARKETS FOR THE NOSE WITH THE PURPOSE OF SEARCHING FOR FUTURE DEVELOPMENT PROSPECTS
by: M. Yu. Kinev, et al.
Published: (2019-01-01)

Pharmaceuticals prepared by continuous polymer technologies
by: Gy. Marosi
Published: (2012-05-01)

The Interconnection Between Pharmaceutical Development and Preclinical Research (Review)
by: I. N. Ampilogova, et al.
Published: (2023-05-01)

Pharmaceutical and non-pharmaceutical antihypertensive therapy in Type 2 diabetes mellitus patients
by: S. G. Malishevsky
Published: (2006-04-01)

DRUGS EFFICIENCY AND SAFETY: THE ROLE OF PHARMACEUTICAL INDUSTRY
by: F. I. Belyalov
Published: (2015-09-01)

Drug development /
Published: (1990)